Comparison of endothelial progenitor cell function in type 2 diabetes with good and poor glycemic control

BMC Endocrine Disorders

Volumn 10, Issue , 2010, Pages

  Churdchomjan, Worachat ^a   Kheolamai, Pakpoom ^a   Manochantr, Sirikul ^a   Tapanadechopone, Pirath ^a   Tantrawatpan, Chairat ^a   U pratya, Yaowalak ^b   Issaragrisil, Surapol ^b  

^a THAMMASAT UNIVERSITY   (Thailand)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

1,1' DIOCTADECYL 3,3,3',3' TETRAMETHYLINDOCARBOCYANINE; ACETYL LOW DENSITY LIPOPROTEIN; CD34 ANTIGEN; GLUCOSE; HEMOGLOBIN A1C; ULEX EUROPAEUS AGGLUTININ; ULEX EUROPAEUS AGGLUTININ 1; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL COUNT; CELL FUNCTION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VITRO STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; STEM CELL;

EID: 77950674825     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-10-5     Document Type: Article

References (46)

1. Hristov M, Zernecke A, Liehn EA, Weber C. Regulation of endothelial progenitor cell homing after arterial injury. ThrombHaemost 2007, 98(2):274-7.
2. Miller-Kasprzak E, Jagodzinski PP. Endothelial progenitor cells as a new agent contributing to vascular repair. Arch Immunol Ther Exp(Warsz) 2007, 55(4):247-59. 10.1007/s00005-007-0027-5, 17659378.
3. Ballard VL, Edelberg JM. Targets for regulating angiogenesis in the aging endothelium. Expert Opin Ther Targets 2007, 11(11):1385-99. 10.1517/14728222.11.11.1385, 18028005.
4. Werner N, Nickenig G. Clinical and therapeutical implications of EPC biology in atherosclerosis. J Cell Mol Med 2006, 10(2):318-32. 10.1111/j.1582-4934.2006.tb00402.x, 16796802.
5. Asahara T, Murohara T, Sullivan MA, Silver M, Zee R, Li T, et al. Isolation of putative progenitor endothelialcells for angiogenesis. Science 1997, 275:964-7. 10.1126/science.275.5302.964, 9020076.
6. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells andcardiovascular outcomes. N Engl J Med 2005, 353(10):999-1007. 10.1056/NEJMoa043814, 16148285.
7. Fadini GP, Sartore S, Schiavon M, Albiero M, Baesso I, Cabrelle A, et al. Diabetes impairs progenitor cell mobilization after hindlimb ischaemia-reperfusion injury in rats. Diabetologia 2006, 49(12):3075-84. 10.1007/s00125-006-0401-6, 17072586.
8. Mukai N, Akahori T, Komaki M, Li Q, Kanayasu-Toyoda T, Ishii-Watabe A, et al. A comparison of the tube forming potentials of early and late endothelial progenitor cells. Exp Cell Res 2008, 314(3):430-40. 10.1016/j.yexcr.2007.11.016, 18083163.
9. Fadini GP, Baesso I, Albiero M, Sartore S, Agostini C, Avogaro A. Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis 2008, 197(2):496-503. 10.1016/j.atherosclerosis.2007.12.039, 18249408.
10. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 2004, 95(4):343-53. 10.1161/01.RES.0000137877.89448.78, 15321944.
11. Tepper OM, Galiano RD, Capla JM, Kalka C, Gagne PJ, Jacobowitz GR, et al. Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 2002, 106(22):2781-6. 10.1161/01.CIR.0000039526.42991.93, 12451003.
12. Loomans CJ, De Koning EJ, Staal FJ, Rabelink TJ, Zonneveld AJ. Endothelial progenitor cell dysfunction in type 1 diabetes: another consequence of oxidative stress?. Antioxid Redox Signal 2005, 7(11-12):1468-75. 10.1089/ars.2005.7.1468, 16356109.
13. Ding H, Triggle CR. Endothelial cell dysfunction and the vascular complications associated with type II diabetes: assessing the health of the endothelium. Vasc Health Risk Manag 2005, 1(1):55-71. 10.2147/vhrm.1.1.55.58939, 1993929, 17319098.
14. Snyder RJ. Controversies regarding vascular disease in the patient with diabetes: a review of the literature. Ostomy Wound Manage 2007, 53(11):40-8.
15. American Diabetes Association (ADA) Clinical practice recommendation. Diabetes Care 2002, 25(Suppl 1):S1-147. American Diabetes Association (ADA).
16. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M, et al. Number and function of endothelial progenitorcells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006, 26(9):2140-6. 10.1161/01.ATV.0000237750.44469.88, 16857948.
17. Mosmann T. Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays. JImmunol Methods 1983, 65:55-63.
18. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V. J Immunol Methods 1995, 184:39-51. 10.1016/0022-1759(95)00072-I, 7622868.
19. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89(1):E1-7. 10.1161/hh1301.093953, 11440984.
20. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial pregenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348:593-600. 10.1056/NEJMoa022287, 12584367.
21. Loomans CJM, de Koning EJP, Staal FJT, Rookmaaker MB, Verseyden C, de Boer HC, et al. Endothelial progenitor cell dysfunction - A novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004, 53(1):195-9. 10.2337/diabetes.53.1.195, 14693715.
22. Fadini GP, Miorin M, Facco M, Bonamico S, Baesso I, Grego F, et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type II diabetes mellitus. J Am CollCardiol 2005, 45:1149-57.
23. Fadini GP, Sartore S, Albiero M, Baesso I, Murphy E, Menegolo M, et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006, 26(9):2140-6. 10.1161/01.ATV.0000237750.44469.88, 16857948.
24. Fadini GP, Pucci L, Vanacore R, Baesso I, Penno G, Balbarini A, et al. Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia 2007, 50(10):2156-63. 10.1007/s00125-007-0732-y, 17579827.
25. Hill JM, Zalos G, Halcox JPJ, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003, 348(7):593-600. 10.1056/NEJMoa022287, 12584367.
26. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events - Proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005, 111(22):2981-7. 10.1161/CIRCULATIONAHA.104.504340, 15927972.
27. Rosenzweig A. Circulating endothelial progenitors-cellsas biomarkers. N Engl J Med 2005, 353(10):1055-7. 10.1056/NEJMe058134, 16148292.
28. Fadini GP, Agostini C, Sartore S, Avogaro A. Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis 2007, 194(1):46-54. 10.1016/j.atherosclerosis.2007.03.046, 17493626.
29. Gallagher KA, Liu ZJ, Xiao M, Chen H, Goldstein LJ, Buerk DG, et al. Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 2007, 117(5):1249-59. 10.1172/JCI29710, 1857264, 17476357.
30. Kuki S, Imanishi T, Kobayashi K, Matsuo Y, Obana M, Akasaka T. Hyperglycemia accelerated endothelial progenitor cell senescence via the activation of p38 mitogen-activated protein kinase. Circ J 2006, 70(8):1076-81. 10.1253/circj.70.1076, 16864945.
31. Catrina SB, Okamoto K, Pereira T, Brismar K, Poellinger L. Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability andfunction. Diabetes 2004, 53(12):3226-32. 10.2337/diabetes.53.12.3226, 15561954.
32. Seeger FH, Haendeler J, Walter DH, Rochwalsky U, Reinhold J, Urbich C, et al. p38 mitogen-activated protein kinase downregulates endothelial progenitor cells. Circulation 2005, 111(9):1184-91. 10.1161/01.CIR.0000157156.85397.A1, 15753227.
33. Marchetti V, Menghini R, Rizza S, Vivanti A, Feccia T, Lauro D, et al. Benfotiamine counteracts glucose toxicity effects on endothelial progenitor cell differentiation via Akt/FoxO signaling. Diabetes 2006, 55(8):2231-7. 10.2337/db06-0369, 16873685.
34. Krankel N, Adams V, Linke A, Gielen S, Erbs S, Lenk K, et al. Hyperglycemia reduces survival and impairs function of circulating blood-derived progenitor cells. Arterioscler Thromb VascBiol 2005, 25(4):698-703.
35. Minami R, Muta K, Umemura T, Motomura S, Abe Y, Nishimura J, et al. p16 (INK4a) induces differentiation and apoptosis in erythroid lineage cells. Exp Hematol 2003, 31:355-62. 10.1016/S0301-472X(03)00040-7, 12763133.
36. Shukla S, Gupta S. Molecular mechanisms for apigenin-induced cell-cycle arrest and apoptosis of hormone refractory human prostate carcinoma DU145 cells. Mol Carcinog 2004, 39:114-26. 10.1002/mc.10168, 14750216.
37. Seeger FH, Chen L, Spyridopoulos I, Altschmied J, Aicher A, Haendeler J. Downregulation of ETS rescues diabetes-induced reduction of endothelial progenitor cells. PLoS ONE 2009, 4(2):e4529. 10.1371/journal.pone.0004529, 2639694, 19225563.
38. Callaghan MJ, Ceradini DJ, Gurtner GC. Hyperglycemia-induced reactive oxygen species and impaired endothelial progenitor cell function. Antioxid Redox Signal 2005, 7(11-12):1476-82. 10.1089/ars.2005.7.1476, 16356110.
39. Fujii H, Li SH, Szmitko PE, Fedak PW, Verma S. C-reactiveprotein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2006, 26(11):2476-82. 10.1161/01.ATV.0000242794.65541.02, 16931792.
40. Rolo A, Palmeira C. Diabetes and mitochondrial function: Role of hyperglycemia and oxidative stress. Toxicol Appl Pharmacol 2006, 212:167-78. 10.1016/j.taap.2006.01.003, 16490224.
41. He T, Peterson TE, Holmuhamedov EL, Terzic A, Caplice NM, Oberley LW, et al. Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase. Arterioscler Thromb Vasc Biol 2004, 24(11):2021-7. 10.1161/01.ATV.0000142810.27849.8f, 15319267.
42. Chen YH, Lin SJ, Lin FY, Wu TC, Tsao CR, Huang PH, et al. High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms. Diabetes 2007, 56(6):1559-68. 10.2337/db06-1103, 17389326.
43. Kim I, Kim HG, So JN, Kim JH, Kwak HJ, Koh GY. Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. Circ Res 2000, 86(1):24-9.
44. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature 1999, 399(6736):597-601. 10.1038/21218, 10376602.
45. Ho FM, Lin WW, Chen BC, Chao CM, Yang CR, Lin LY, et al. High glucose-induced apoptosis in human vascular endothelial cells is mediated through NF-kappaB and c-Jun NH2-terminal kinase pathway and prevented by PI3K/Akt/eNOS pathway. Cell Signal 2006, 18(3):391-9. 10.1016/j.cellsig.2005.05.009, 15970429.
46. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359(15):1577-89. 10.1056/NEJMoa0806470, 18784090.